Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
New research suggests combining GLP-1 drugs like Ozempic and menopause hormone treatment may be even more beneficial
Similar patterns appeared in other obesity-related cancers: Non-small cell lung cancer: progression to Stage IV roughly 10% versus 22% Colorectal cancer: statistically significant reduction in progression Hepatocellular (liver) cancer: signal in the same direction A separate JAMA Oncology study by Dai and colleagues (2025), distinct from the Cleveland Clinic ASCO analysis, found about a 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists, with most of the signal coming from skin cancers and obesity-related solid tumors
Why do I want to eat more
Nutr And Cancer (2020) 72:7487
The Participant Center: U24 OD023176
.png?w=1280&max-h=720&fit=crop&auto=format)
